核蛋白因子p8对非小细胞肺癌细胞自噬的转录调节及其生物学功能

基本信息
批准号:81572271
项目类别:面上项目
资助金额:55.00
负责人:马振毅
学科分类:
依托单位:天津医科大学
批准年份:2015
结题年份:2019
起止时间:2016-01-01 - 2019-12-31
项目状态: 已结题
项目参与者:孙冰生,杨洁,孙亚楠,闫晓洁,高丹,赵丹,穆艳超,王玲玲,张华
关键词:
肺肿瘤衰亡转录调节因子细胞自噬自噬溶酶体外排
结项摘要

Under a variety of stressful conditions, autophagy, a highly regulated cellular self-degradation process, is an obligate requirement for cancer cell survival. A aberrantly balance between autophagic survival and cell death is believed to drive all stages of cancer progression. However, the mechanisms of autophagic survival and cell death regulation in cancer cells which distinctly modulate cells to allow autophagic survival remain largely elusive. Our preliminary data showed that p8 (also called nuclear protein 1), a transcriptional regulator mediates autophagic survival in non-small cell lung cancer cells (NSCLCs) and plays an important role in NSCLC progression. Experimental validation shows that p8 regulates the late stages of autolysosomal process via SNAP-25-mediated autolysosomal exocytosis for cellular clearance as well as autophagic flux pathways. Inactivation of p8 causes enhanced autophagic flux alongside a persistent reduction in autolysosomal exocytosis and consequently triggers intrinsic senescent cell death with autolysosomal vacuolization, resulting in tumor suppression. Mechanistically, p8 knockdown impairs autophagic flux and lysosomal exocytosis, and induces rather autolysosome-dependent senescence than apoptosis, resulting in tumor suppression in vitro and in vivo. These findings indicate a significant and novel function of p8 as a potent regulator of autolysosomal process in diverse cancer cell demise decision. Along with our preliminary data demonstrating that p8 significantly correlates with NSCLCs, we propose here that inactivation of p8 expression and enhanced autophagy pathway might be a promising strategy to inhibit lung cancer survival. To test this hypothesis, we will use clinical lung cancer samples, lung cancer cell lines as well as mouse model to investigate the crosstalk between autophagic survival and autophagic cell death mediated by p8 in vitro and in vivo. The on-going project of p8 functional investigation will be initially focused on the interacting protein partners with p8 by Nano-HPLC/mass spectrometric analysis and their validation by DuoLink and co-immunoprecipitation, respectively. These interaction may regulate the downstream pathways of p8 which regulate autophagy at the transcription level. Based on our experimental data, the regulatory pathways of autophagic survival and cell death will be elucidated and evaluated in clinical NSCLC samples as new candidates for autophagic survival. Hopefully, we may gain significant insight into the autophagic survival and autophagic cell death events associated with lung cancer progression and add to means of assessing suppression of p8 and impaired autophagy for prevention of NSCLC incidence. Also, a better understanding of the role of p8 underlying autophagic survival and autophagic cell death including the determination of the upstream regulators and downstream effectors of p8 functional pathways may lead to the development of novel anti-tumor strategies.

近年来,细胞自噬性存活和死亡的命运决定是肿瘤研究领域的热点和难点之一。我们前期的实验结果表明核蛋白因子p8通过调控自噬溶酶体途径的基因转录,维持自噬依赖的细胞存活;当下调该基因表达时,肺癌细胞出现囊泡化,并导致衰亡;动物实验也显示下调p8显著抑制肺癌细胞体内成瘤;分子机制上表明p8调控SNAP-25的转录,SNAP-25可能介导自噬溶酶体的外排,并且非小细胞肺癌临床样品中p8和SNAP-25表达显著增强,提示作为调控自噬途径的关键转录因子p8,调控细胞自噬性存活和死亡途径。本课题期望在现有实验基础上深入研究非小细胞肺癌发生发展过程中p8协调细胞自噬性存活和死亡的调控机制,依据实验结果阐明p8介导的自噬调控途径,并在非小细胞肺癌样品中加以验证,同时探讨基于p8生物学效应而进行的抑制肺癌细胞体内存活的可行性。研究结果将有助于了解非小细胞肺癌中细胞自噬调控途径,丰富对肺癌发生发展分子机制的认识。

项目摘要

近年来,细胞自噬性存活和死亡的命运决定是肿瘤研究领域的热点和难点之一,这似乎取决于细胞所处的内外环境,但精细的调控机制未知。本课题中我们通过研究核蛋白因子p8调控自噬溶酶体途径的基因转录,发现p8维持自噬依赖的细胞存活;当下调该基因表达时,肺癌细胞出现囊泡化,并导致早熟性衰亡,动物实验也显示下调p8显著抑制肺癌细胞体内成瘤;分子机制上的实验表明p8维持SNAP25的转录,SNAP25介导自噬溶酶体的外排,产生的胞外囊泡也可能参与了临近细胞的自噬性存活;非小细胞肺癌临床样品中p8和SNAP25表达显著增强,提示作为调控自噬途径的关键转录因子p8,调控细胞自噬性存活和死亡途径。据此,我们提出:存活的肿瘤细胞存在一个自噬流量和自噬溶酶体外排流量的平衡;如果在自噬流量增加的前提下,自噬溶酶体外排流量的抑制将不利于肿瘤细胞的存活。此外,SNAP25所在的SNAREs复合物对于依赖自噬溶酶体存活的肿瘤细胞至关重要,基于SNAREs复合物的机制研究也在进行中;这些研究结果丰富了对肺癌发生发展分子机制的认识,有助于进一步了解非小细胞肺癌中细胞自噬调控途径,也为后续的研究提供了思路和方向。

项目成果
{{index+1}}

{{i.achievement_title}}

{{i.achievement_title}}

DOI:{{i.doi}}
发表时间:{{i.publish_year}}

暂无此项成果

数据更新时间:2023-05-31

其他相关文献

1

DeoR家族转录因子PsrB调控黏质沙雷氏菌合成灵菌红素

DeoR家族转录因子PsrB调控黏质沙雷氏菌合成灵菌红素

DOI:10.3969/j.issn.1673-1689.2021.10.004
发表时间:2021
2

转录组与代谢联合解析红花槭叶片中青素苷变化机制

转录组与代谢联合解析红花槭叶片中青素苷变化机制

DOI:
发表时间:
3

视网膜母细胞瘤的治疗研究进展

视网膜母细胞瘤的治疗研究进展

DOI:
发表时间:2018
4

当归补血汤促进异体移植的肌卫星细胞存活

当归补血汤促进异体移植的肌卫星细胞存活

DOI:
发表时间:2016
5

TGF-β1-Smad2/3信号转导通路在百草枯中毒致肺纤维化中的作用

TGF-β1-Smad2/3信号转导通路在百草枯中毒致肺纤维化中的作用

DOI:10.13692/ j.cnki.gywsy z yb.2016.03.002
发表时间:2016

马振毅的其他基金

批准号:81071730
批准年份:2010
资助金额:31.00
项目类别:面上项目
批准号:81372307
批准年份:2013
资助金额:73.00
项目类别:面上项目
批准号:81872350
批准年份:2018
资助金额:57.00
项目类别:面上项目

相似国自然基金

1

转录调控因子Nupr1在非小细胞肺癌细胞中的自噬调控机制

批准号:81401884
批准年份:2014
负责人:闫晓洁
学科分类:H1819
资助金额:23.00
项目类别:青年科学基金项目
2

Rab25抑制非小细胞肺癌细胞自噬的机制研究

批准号:81702245
批准年份:2017
负责人:杨洁
学科分类:H1803
资助金额:20.00
项目类别:青年科学基金项目
3

BRSK2调控自噬促进非小细胞肺癌细胞转移的机制

批准号:81874039
批准年份:2018
负责人:闫晓洁
学科分类:H1808
资助金额:57.00
项目类别:面上项目
4

自噬相关转录因子上调细胞自噬促进肝癌转移的机制及基于自噬转录调节的肝癌组织特异性靶向治疗研究

批准号:81572296
批准年份:2015
负责人:彭远飞
学科分类:H1815
资助金额:57.00
项目类别:面上项目